First Time Loading...

Evaxion Biotech A/S
NASDAQ:EVAX

Watchlist Manager
Evaxion Biotech A/S Logo
Evaxion Biotech A/S
NASDAQ:EVAX
Watchlist
Price: 3.91 USD -1.01% Market Closed
Updated: May 7, 2024

Evaxion Biotech A/S
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Evaxion Biotech A/S
Revenue Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Evaxion Biotech A/S
NASDAQ:EVAX
Revenue
$73k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Revenue
kr16.5B
CAGR 3-Years
18%
CAGR 5-Years
40%
CAGR 10-Years
38%
Zealand Pharma A/S
CSE:ZEAL
Revenue
kr342.8m
CAGR 3-Years
21%
CAGR 5-Years
55%
CAGR 10-Years
48%
Ascendis Pharma A/S
NASDAQ:ASND
Revenue
€329m
CAGR 3-Years
291%
CAGR 5-Years
83%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Revenue
kr7.1B
CAGR 3-Years
56%
CAGR 5-Years
70%
CAGR 10-Years
19%
Bioporto A/S
CSE:BIOPOR
Revenue
kr31m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
6%

See Also

What is Evaxion Biotech A/S's Revenue?
Revenue
73k USD

Based on the financial report for Dec 31, 2023, Evaxion Biotech A/S's Revenue amounts to 73k USD.